{
  "id": "5c4653b9368b7bc8",
  "title": "U . S . FDA Approves NUZOLVENCE\u00ae ( zoliflodacin ), a First - in - Class , Single - dose , Oral Antibiotic for the",
  "description": "20251213T051500Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2025-12-13-5/us-fda-approves-nuzolvence-zoliflodacin-a-first-in-class-single-dose-oral-antibiotic-for-the",
  "published_at": "20251213T051500Z",
  "fetched_at": "2025-12-14T00:25:01.294421+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "antibiotic"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2025-12-13-5/us-fda-approves-nuzolvence-zoliflodacin-a-first-in-class-single-dose-oral-antibiotic-for-the",
    "url_mobile": "",
    "title": "U . S . FDA Approves NUZOLVENCE\u00ae ( zoliflodacin ), a First - in - Class , Single - dose , Oral Antibiotic for the",
    "seendate": "20251213T051500Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}